Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when IRTC files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsiRhythm appoints Jason Patten to Board and Audit Committee effective March 12
Filed March 12, 2026 · Period ending March 12, 2026 · ~1 min read
Key Changes
-
medium
Jason Patten joined iRhythm's Board of Directors and Audit Committee on March 12, 2026, serving until the 2026 Annual Meeting. The Board determined he meets Nasdaq independence standards and SEC audit committee requirements.
Item 5.02 verify on EDGAR → -
low
Patten received standard director compensation: $300,000 in restricted stock units vesting over three years, plus annual cash retainers of $55,000 for Board service and $10,000 for Audit Committee service.
Item 5.02 verify on EDGAR → -
low
Before his Board appointment, Patten served as an advisor to the CEO and received a one-time payment of $86,771 for those services, disclosed for transparency about the prior relationship.
Item 5.02 verify on EDGAR →
Summary
iRhythm Holdings expanded its Board of Directors by appointing Jason Patten as an independent director and Audit Committee member, effective March 12, 2026. The appointment follows standard corporate governance practices, with Patten meeting both Nasdaq independence requirements and SEC audit committee qualifications. His term runs through the company's 2026 Annual Meeting.
For retail investors, this is a routine governance matter with minimal immediate impact. Board composition changes can signal strategic shifts, but this appears to be standard board refreshment. Patten's prior advisory role to the CEO suggests existing familiarity with the company's operations, which could enable faster contribution to board oversight.
Watch for proxy materials ahead of the 2026 Annual Meeting, which will provide Patten's full background and qualifications. His Audit Committee role means he'll oversee financial reporting and internal controls—areas worth monitoring in upcoming quarterly filings for any changes in disclosure practices or accounting policies.
Section-by-Section Diff
Event · Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation
Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation filed; see Key Changes for terms.
Added in current filing · verify on EDGAR →
Effective as of March 12, 2026, the Board of Directors (the "Board") of iRhythm Holdings, Inc., a Delaware corporation (the "Company") appointed Jason Patten as a director of the Board and member of the Audit Committee of the Board (the “Audit Committee”). Mr. Patten shall hold office for a term expiring at the 2026 Annual Meeting of the Company’s stockholders.
The company appointed Jason Patten as a new director and Audit Committee member effective March 12, 2026. His term will expire at the 2026 Annual Meeting. The Board determined he qualifies as an independent director under Nasdaq listing standards and meets SEC audit committee requirements.
Event · Item 7.01 — Regulation FD Disclosure
iRhythm announced the appointment of Mr. Patten to the Board of Directors via press release.
Added in current filing · verify on EDGAR →
The Company announced the appointment of Mr. Patten to the Board in a press release furnished as Exhibit 99.1 to this Current Report on Form 8-K.
iRhythm Holdings disclosed the appointment of Mr. Patten to its Board of Directors. The announcement was made through a press release attached as an exhibit to this 8-K filing. No additional details about Mr. Patten's background, committee assignments, or compensation are provided in the 8-K body itself.
Event · Item 9.01 — Financial Statements and Exhibits
iRhythm filed an 8-K attaching a press release dated March 12, 2026; no material event details disclosed in the filing body.
Added in current filing · view on EDGAR →
99.1 Press release dated March 12, 2026
The 8-K references an attached press release dated March 12, 2026, but does not disclose the content or subject matter of that release within the filing body itself. Without access to Exhibit 99.1, the nature and materiality of the disclosed event cannot be determined from this filing.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 4, 2026 · How we verify